Annual FCF
-$32.20 M
+$7.14 M+18.16%
December 31, 2023
Summary
- As of February 8, 2025, SNSE annual free cash flow is -$32.20 million, with the most recent change of +$7.14 million (+18.16%) on December 31, 2023.
- During the last 3 years, SNSE annual FCF has fallen by -$13.29 million (-70.29%).
- SNSE annual FCF is now -273.41% below its all-time high of -$8.62 million, reached on December 31, 2019.
Performance
SNSE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$5.47 M
+$431.00 K+7.30%
September 30, 2024
Summary
- As of February 8, 2025, SNSE quarterly free cash flow is -$5.47 million, with the most recent change of +$431.00 thousand (+7.30%) on September 30, 2024.
- Over the past year, SNSE quarterly FCF has increased by +$693.00 thousand (+11.24%).
- SNSE quarterly FCF is now -97.54% below its all-time high of -$2.77 million, reached on June 30, 2020.
Performance
SNSE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$25.19 M
-$809.00 K-3.32%
September 30, 2024
Summary
- As of February 8, 2025, SNSE TTM free cash flow is -$25.19 million, with the most recent change of -$809.00 thousand (-3.32%) on September 30, 2024.
- Over the past year, SNSE TTM FCF has increased by +$7.02 million (+21.79%).
- SNSE TTM FCF is now -286.78% below its all-time high of -$6.51 million, reached on March 31, 2020.
Performance
SNSE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SNSE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.2% | +11.2% | +21.8% |
| 3 y3 years | -70.3% | +42.9% | +36.0% |
| 5 y5 years | -211.3% | +42.9% | +36.0% |
SNSE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.2% | -17.4% | +54.2% | -3.3% | +37.8% |
| 5 y | 5-year | -273.4% | +18.2% | -97.5% | +54.2% | -286.8% | +37.8% |
| alltime | all time | -273.4% | +18.2% | -97.5% | +54.2% | -286.8% | +37.8% |
Sensei Biotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.47 M(-7.3%) | -$25.19 M(+3.3%) |
| Jun 2024 | - | -$5.90 M(-22.9%) | -$24.38 M(-12.8%) |
| Mar 2024 | - | -$7.65 M(+24.2%) | -$27.97 M(-13.1%) |
| Dec 2023 | -$32.20 M(-18.2%) | -$6.16 M(+32.2%) | -$32.20 M(-9.6%) |
| Sep 2023 | - | -$4.66 M(-50.9%) | -$35.61 M(-6.3%) |
| Jun 2023 | - | -$9.49 M(-20.1%) | -$38.01 M(-6.1%) |
| Mar 2023 | - | -$11.89 M(+24.2%) | -$40.47 M(+2.8%) |
| Dec 2022 | -$39.35 M | -$9.57 M(+35.7%) | -$39.35 M(+3.1%) |
| Sep 2022 | - | -$7.05 M(-41.0%) | -$38.18 M(+2.9%) |
| Jun 2022 | - | -$11.95 M(+11.0%) | -$37.09 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.77 M(+28.2%) | -$31.80 M(-1.5%) |
| Dec 2021 | -$32.28 M(+70.7%) | -$8.40 M(+40.9%) | -$32.28 M(+20.1%) |
| Sep 2021 | - | -$5.96 M(-10.5%) | -$26.88 M(-2.4%) |
| Jun 2021 | - | -$6.66 M(-40.8%) | -$27.55 M(+16.5%) |
| Mar 2021 | - | -$11.25 M(+275.6%) | -$23.65 M(+25.1%) |
| Dec 2020 | -$18.91 M(+119.3%) | -$3.00 M(-54.8%) | -$18.91 M(+18.8%) |
| Sep 2020 | - | -$6.63 M(+139.6%) | -$15.91 M(+71.5%) |
| Jun 2020 | - | -$2.77 M(-57.5%) | -$9.28 M(+42.5%) |
| Mar 2020 | - | -$6.51 M | -$6.51 M |
| Dec 2019 | -$8.62 M(-16.6%) | - | - |
| Dec 2018 | -$10.34 M | - | - |
FAQ
- What is Sensei Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual FCF year-on-year change?
- What is Sensei Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly FCF year-on-year change?
- What is Sensei Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics TTM FCF year-on-year change?
What is Sensei Biotherapeutics annual free cash flow?
The current annual FCF of SNSE is -$32.20 M
What is the all time high annual FCF for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual free cash flow is -$8.62 M
What is Sensei Biotherapeutics annual FCF year-on-year change?
Over the past year, SNSE annual free cash flow has changed by +$7.14 M (+18.16%)
What is Sensei Biotherapeutics quarterly free cash flow?
The current quarterly FCF of SNSE is -$5.47 M
What is the all time high quarterly FCF for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly free cash flow is -$2.77 M
What is Sensei Biotherapeutics quarterly FCF year-on-year change?
Over the past year, SNSE quarterly free cash flow has changed by +$693.00 K (+11.24%)
What is Sensei Biotherapeutics TTM free cash flow?
The current TTM FCF of SNSE is -$25.19 M
What is the all time high TTM FCF for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high TTM free cash flow is -$6.51 M
What is Sensei Biotherapeutics TTM FCF year-on-year change?
Over the past year, SNSE TTM free cash flow has changed by +$7.02 M (+21.79%)